DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical
Analytical Testing Outsourcing Market Size, Share & Trends Analysis
Report By Service (Bioanalytical, Stability Testing, Method Development
& Validation), And Segment Forecasts, 2019 – 2026” report
has been added to ResearchAndMarkets.com’s offering.
The global pharmaceutical analytical testing outsourcing market size is
projected to reach USD 10.4 billion by 2026 expanding at a CAGR of 8.1%.
Focus on the analytical testing of biopharmaceuticals and biosimilars,
adoption of Full Time Equivalent Agreements (FTE), and increased
outsourcing of analytical testing services to contract pharma companies
are propelling the market growth.
Demand for biosimilars and pharmaceutical drugs is expected to increase
substantially over the forecast period. Thus, to fulfil the rising
demand, key pharmaceutical companies and government bodies are working
collaboratively.
For instance, in August 2018, the Swedish government collaborated with
GE Healthcare to establish a new innovation center for testing of new
discoveries in the pharmaceutical sector.
Major companies may lack the required manufacturing set-up and expertise
to carry out in-house testing services. This leads to the outsourcing of
in-house work to contract pharmaceutical companies. In addition, several
ancillary works, such as registration, storage and testing, process and
facility validation, and cleaning validations, are outsourced to remain
competitive in the market. These factors will boost the market growth in
the years to come.
Further key findings from the study suggest:
-
Clinical bioanalytical testing services is projected to be the largest
service segment over the forecast period -
Increasing number of clinical trial registrations and entry of new
contract pharma companies are the factors responsible for the segment
growth -
North America led the global pharmaceutical analytical testing
outsourcing market in 2018 due to government support and strong
presence of key pharmaceutical outsourcing companies -
Some of the key companies in the market are SGS SA; Intertek Group
PLC; Pharmaceutical Product Development, LLC; Toxikon, Inc.; Exova
Group PLC, Eurofins Scientific; Pace Analytical Services, LLC; Charles
River Laboratories International, Inc.; Boston Analytical, Inc.; and
West Pharmaceutical Services, Inc
Key Topics Covered
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information procurement
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Pharmaceutical Analytical Testing Outsourcing Market
Variables, Trends & Scope
3.1 Market Lineage outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis, by Stage
3.4 User perspective analysis
3.5 List of Key End-users, by region / by product / by country
3.6 Regulatory Framework
3.7 Market Dynamics
3.8 Pharmaceutical Analytical Testing Outsourcing: Market Analysis Tools
Chapter 4 Pharmaceutical Analytical Testing Outsourcing Market: Segment
Analysis, By Service, 2015 – 2026 (USD Million)
4.1 Definitions & Scope
4.2 Services market share analysis, 2018 & 2026
4.3 Segment Dashboard
4.4 Global Pharmaceutical Analytical Testing Outsourcing Market, by
Service, 2015 to 2026
4.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the
following
Chapter 5 Pharmaceutical Analytical Testing Outsourcing Market: Regional
Market Analysis, 2015 – 2026 (USD Million)
5.1 Definitions & Scope
5.2 Regional market share analysis, 2018 & 2026
5.3 Regional Market Dashboard
5.4 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key
Players, Top Trends)
5.5 Regional Market Share and Leading Players, 2018
5.6 SWOT Analysis, by Factor (Political & Legal, Economic And
Technological)
5.7 Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2026:
5.8 North America
5.9 Europe
5.10 Asia Pacific
5.11 Latin America
5.12 Middle East & Africa
Chapter 6 Pharmaceutical Analytical Testing Outsourcing Market –
Competitive Analysis
6.1 Recent developments & impact analysis, by key market participants
6.2 Company/Competition Categorization (Key innovators, Market leaders,
Emerging players)
6.3 Vendor Landscape
6.4 Public Companies
6.5 Private Companies
6.6 Supplier Ranking
6.7 Key companies profiled
6.7.1 SGS S.A.
6.7.2 Toxikon Inc.
6.7.3 Eurofins Scientific
6.7.4 Pace Analytical Services LLC
6.7.5 Intertek Group PLC
6.7.6 Pharmaceutical Product Development LLC.
6.7.7 Exova Group PLC
6.7.8 Boston Analytical
6.7.9 Charles River Laboratories International Inc.
6.7.10 West Pharmaceutical Services
For more information about this report visit https://www.researchandmarkets.com/r/p7u1hx
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Pharmaceutical
Manufacturing